NaturalShrimp Inc (SHMP): The patent is useless because it describ...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	27
Posts	11315
Boards Moderated	1
Alias Born	10/06/2011

JoshTaeger

Re: MFranny post# 89554

Monday, 12/21/2020 10:29:19 AM

Monday, December 21, 2020 10:29:19 AM

The patent is useless because it describes “tech” that didn’t work and had to be fixed by paying Hydrenesis for their “tech”. Gotta watch the pea under the cup here.

I'm here for the entertainment and to entertain. I'm certainly not here to give financial advice and anyone who thinks otherwise is a fool.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SHMP News

Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:30:30 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:31:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:30:31 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:56:11 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 10:01:21 PM
Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/08/2023 03:52:31 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 08:31:49 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/15/2023 04:15:19 AM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 09:20:31 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/11/2023 08:52:47 PM
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/07/2023 09:04:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2023 09:20:28 PM

More SHMP News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover